European CAB Criteria For MRA Participation Under Development By FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is developing quantifiable criteria to evaluate European conformity assessment bodies (CABs) seeking agency approval to participate in the operational phase of the mutual recognition agreement between the U.S. and the European Union.